✦ LIBER ✦

Sustained Low Clinical Event Rates in Real-World Patients Receiving Everolimus-Eluting Coronary Stent System from a Large, Prospective, Condition of Approval Study: 2-Year Clinical Outcomes from the XIENCE V® USA Study

✍ Scribed by JAMES B. HERMILLER; DAVID R. RUTLEDGE; LUIS GRUBERG; JOHN N. KATOPODIS; WILLIAM LOMBARDI; VIVIAN W. MAO; WEIYING ZHAO; SAMIN K. SHARMA; HOSHEDAR P. TAMBOLI; JIN WANG; LALITHA JONNAVITHULA; KRISHNANKUTTY SUDHIR; MITCHELL W. KRUCOFF

Book ID: 117962224
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 914 KB
Volume: 25
Category: Article
ISSN: 0896-4327
DOI: 10.1111/j.1540-8183.2012.00766.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-259: Low Clinical Event Rates In Rea

TCT-259: Low Clinical Event Rates In Real-World Patients Receiving the XIENCE V® Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Treatment of smaller coronary vessels wi

Treatment of smaller coronary vessels with XIENCE V everolimus-eluting stents in real-world patients: 1-year clinical outcomes from the XIENCE V USA study

✍ James Hermiller; David Rutledge; Vivian Mao; Weiying Zhao; Jin Wang; Olivia Wilb 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Treatment of smaller coronary vessels wi

Treatment of smaller coronary vessels with XIENCE V® everolimus-eluting stents in real-world patients: 1-year clinical outcomes from the XIENCE V USA study

✍ James Hermiller; David Rutledge; Vivian Mao; Weiying Zhao; Jin Wang; Olivia Wilb 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 204 KB

TCT-296: Low Clinical Event Rates In Rea

TCT-296: Low Clinical Event Rates In Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: One-Year Results From the XIENCE V USA Study

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 86 KB

TCT-291: Clinical Outcomes In Real-World

TCT-291: Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE V® Everolimus-Eluting Stent (EES): One Year Results From the XIENCE V USA Study

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 137 KB

TCT-214: Safety and Effectiveness of Eve

TCT-214: Safety and Effectiveness of Everolimus-Eluting Stents in 5054 Patients from a Large, Prospective, Real World Study: Two-Year Clinical Outcomes from the XIENCE V® USA Study

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 115 KB